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Optic neuropathy and congenital glaucoma associated with
probable Zika virus infection in Venezuelan patients
C. Gustavo De Moraes,1 Michele Pettito,2 Juan B. Yepez,2 Anavaj Sakuntabhai,3,4 Etienne Simon-Loriere,3,4
Mussaret B. Zaidi,5,6 Matthieu Prot,3,4 Claude Ruffie,7,8 Susan S. Kim,9 Rando Allikmets,1 Joseph D. Terwilliger,10,11,12,13
Joseph H. Lee11,14 and Gladys E. Maestre15,16,17,*

Abstract
Introduction. Although the current Zika virus (ZIKV) epidemic is a major public health concern, most reports have focused on
congenital ZIKV syndrome, its most devastating manifestation. Severe ocular complications associated with ZIKV infections
and possible pathogenetic factors are rarely described. Here, we describe three Venezuelan patients who developed severe
ocular manifestations following ZIKV infections. We also analyse their serological response to ZIKV and dengue virus (DENV).
Case presentation. One adult with bilateral optic neuritis, a child of 4 years of age with retrobulbar uveitis and a newborn
with bilateral congenital glaucoma had a recent history of an acute exanthematous infection consistent with ZIKV infection.
The results of ELISA tests indicated that all patients were seropositive for ZIKV and four DENV serotypes.
Conclusion. Patients with ZIKV infection can develop severe ocular complications. Anti-DENV antibodies from previous
infections could play a role in the pathogenesis of these complications. Well-designed epidemiological studies are urgently
needed to measure the risk of ZIKV ocular complications and confirm whether they are associated with the presence of antiflaviviral antibodies.

microcephaly were reported in Brazil [7]. ZIKV outbreaks
in North, Central and South America and the Caribbean followed, with significant regional differences in the scale,
speed of transmission, and distribution of adverse outcomes
[8]. These differences presumably resulted from a combination of interacting risk factors, such as demographic and
health status of the local host populations, and characteristics of the vector and its surrounding environment. Other
factors, such as health care accessibility, efficiency of reporting systems and health policies, could also affect the regional
prevalence of ZIKV and its complications.

INTRODUCTION
Zika virus (ZIKV) is an arbovirus of the Flaviviridae family.
It can be transmitted by the mosquito Aedes aegypti or
through bodily fluids (e.g. blood, semen, saliva). Following
the virus’ isolation in monkeys in the 1940s [1], it first
appeared in humans in Africa in the 1960s [2]. In 2007, a
large epidemic occurred in Micronesia [3]. Until then, ZIKV
infection was considered benign, given that many infections
presented as a mild form of dengue, with rash, fever, arthralgia and conjunctivitis, and a large proportion of the infections were asymptomatic [4, 5]. Serious outcomes were first
identified during a 2013 Polynesian epidemic in which
excess cases of Guillain–Barre syndrome (GBS), a peripheral
neuropathic condition, were detected [6]; In 2014, GBS and

Severe ocular anomalies have been reported in infants with
congenital ZIKV syndrome [9–12] and, more rarely, among
adults [13–16]; however, none have been reported in
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children of 2 years of age or over. In consequence, the spectrum of severe ocular anomalies beyond congenital ZIKV
syndrome is currently unknown, and our medical and public health practitioners lack sufficient knowledge about its
diagnosis, clinical course and prevention. Optic neuropathy
is defined as damage to the optic nerve (whether in the
globe, orbit or intracranial space) clinically manifested by
partial or total visual loss and/or abnormal findings in ophthalmological assessment. We report three cases of atypical,
severe optic neuropathy, sight-threatening manifestations of
ZIKV infection identified in 2016 in Maracaibo, Venezuela.
Two patients, one adult and one child, were diagnosed with
bilateral optic neuritis. A third patient, a newborn, had
bilateral congenital glaucoma associated with probable vertical transmission of ZIKV.

no sign of anterior uveitis. Fundus examination (Fig. 1a)
and optical coherence tomography (OCT, Fig. 1b) revealed
bilateral swelling of the optic nerve head. Automated perimetry was performed to assess the visual field status. There
was a diffuse loss of contrast sensitivity in both eyes, which
did not respect the horizontal or vertical meridians
(Fig. 1c). Magnetic resonance imaging (MRI) of the brain
was unremarkable (Fig. 1d).
On the basis of the clinical manifestations and ancillary test
results, the patient was diagnosed with bilateral optic neuritis of possible infectious or parainfectious origin. The
absence of ocular pain, bilateral presentation and normal
brain MRI made multiple sclerosis unlikely as the cause of
neuritis. The patient reported no symptoms suggestive of
arteritic ischaemic optic neuropathy, such as mandibular
claudication or temporal headache. Nonarteritic ischaemic
optic neuropathy was also deemed unlikely, given the
absence of underlying vascular disease, hypertension, diabetes or hypercholesterolaemia.

CASE REPORT
Case 1
A 49-year-old woman with no comorbidities was referred to
the ophthalmology clinic for evaluation of sudden painless
bilateral amaurosis. Nineteen days previously, she had been
evaluated at an ambulatory care unit in Maracaibo, Venezuela, with complaints of headache, low fever and myalgia.
Upon ophthalmological examination, the best-corrected
visual acuity (BCVA) was OD 20/60, OS 20/40. There was
mild conjunctival hyperaemia, no corneal abnormalities and

The patient was treated with intravenous methylprednisolone
(250 mg QID) for 3 days, followed by oral prednisolone (1 mg
kg 1 day 1) for 11 days. The patient’s BCVA remained the
same at the most recent ophthalmological examination,
20 months after the onset of symptoms. Fundus examination
no longer revealed optic nerve head swelling, and the visual

Fig. 1. Patient described in Case 1. (a) Fundus photographs showing the optic nerve heads and maculas of the left and right eyes. (b)
Optical coherence tomography (OCT) of the left and right eyes showing optic disc swelling; both macular scans are normal. (c) Visual
field testing results showing diffuse contrast sensitivity loss. (d) Magnetic resonance imaging (MRI) of the brain showing no
abnormalities.
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fields revealed mild improvement. The patient was seropositive for ZIKV and all four DENV serotypes (Table 1).

ZIKV and all four dengue serotypes (Table 1). The patient
received cornea transplants 20 months after the diagnosis.

Case 2
A previously healthy 4-year-old boy was referred to the ophthalmology clinic with sudden bilateral amaurosis. Two weeks
prior to the onset of visual symptoms, the patient had a low
fever, mild rash and myalgia, consistent with clinical manifestations of ZIKV infection. Ophthalmological evaluation
showed that the patient’s BCVA was no light perception in
either eye. Direct and consensual photomotor reflexes were
hyporeactive. Anterior segment examination revealed no corneal abnormalities and no signs of uveitis. Fundus examination revealed optic disc pallor and an oedematous nerve fibre
layer. The remaining fundus examination and MRI were unremarkable (Fig. 2). Due to poor visual acuity, the patient was
unable to undergo OCT or visual field testing. No other ocular
or systemic manifestations were observed.

Assessment of humoral immunity
Sera from all three patients and the newborn’s mother were
obtained when the patients arrived at our clinic for medical
care. Antibody titres for ZIKV and DENV serotypes 1–4
were determined using an in-house ELISA assay. Serum
samples were heat-inactivated for 30 min at 56  C. Microtitre plates were coated with recombinant EDIII protein
(either ZIKV or DENV 1–4) and incubated with serial dilutions of the test sera. Bound antibodies were revealed with
an anti-human immunoglobulin G (IgG)-antibody horseradish peroxidase conjugate (Rockland) and 3,3¢,5,5¢–tetramethylbenzidine (TMB) substrate. The endpoint titre was
calculated as the reciprocal of the highest dilution of individual serum, giving an absorbance of 0.5. All the samples
were processed in the same batch. IgG titres to ZIKV and
DENV 1–4 for each patient are shown in Table 1. All the
sera were also tested for the presence of anti-ZIKV IgM and
IgG antibodies, using a commercial anti-Zika antibody kit
(EUROIMMUN, Lubeck, Germany). All patients were positive for anti-ZIKV IgG by both the in-house assays and the
commercial kit, but none of the sera was positive for antiZIKV IgM antibodies. Neutralization assays were not
performed.

The patient was also diagnosed with optic neuritis of possible infectious or parainfectious origin. He was treated with
intravenous methylprednisolone for 3 days, followed by oral
prednisolone for 11 days. At the last ophthalmological
examination, 35 days after the onset of symptoms, his visual
acuity had improved to light perception in both eyes. The
patient was seropositive for ZIKV and all four serotypes of
dengue (Table 1).

Case 3
A 17-day-old infant was brought in for examination due to
buphthalmia, epiphora, photophobia and blepharospasm
[12]. Both eyes revealed cloudy corneas with diffuse oedema
that precluded examination of the anterior chamber and
fundoscopy. Intraocular pressure was 30 and 33 mm Hg in
the right and left eye, respectively. Corneal diameter was
12.5 mm in each of the eyes. Notably, there were no signs of
microcephaly, and the remaining systemic examination was
unremarkable. The mother reported clinical symptoms
compatible with ZIKV infection around the 25th week of
pregnancy.

DISCUSSION
We report two cases of optic neuropathy in an otherwise
healthy adult and a child, both with probable recent ZIKV
infection. Although we cannot conclusively demonstrate a
causal relationship between ZIKV infection and optic neuritis due to the non-availability of acute samples, these cases
indicate that the clinical manifestations of ZIKV infection
could be more diverse and severe than previously assumed.
Given that severe ocular complications resulting in permanent visual impairment [17, 18] have been associated with
other arboviral infections, their presentation in ZIKV infection is not unexpected.

The patient was diagnosed with congenital glaucoma and
underwent surgery in both eyes (360-degree ab interno trabeculotomy, combined with trabeculectomy). Postoperative
intraocular pressure measurements were 15–20 mm Hg.
Both the patient and her mother had IgG antibodies against

Initial reports of ocular manifestations of ZIKV infection in
children with microcephaly [19] included focal pigment mottling and chorioretinal atrophy, primarily located in the posterior pole of the eye, especially the macular area. Such ocular
manifestations are commonly seen in TORCH infections,
which could reflect similar pathogenetic mechanisms among
these different viral families [20, 21]. Subsequent reports on
ocular pathology of ZIKV included cases of acute maculopathy [13, 14], uveitis [15, 16] and congenital glaucoma [22]. It
is possible that ZIKV can cross the blood–brain barrier and
lead to direct damage and an inflammatory response, even
among healthy adults. This is more plausible among newborns given the immaturity of their nervous and immunological systems. The newborn we hereby describe could
represent a spectrum of congenital manifestations of ZIKV
vertical transmission, even in the absence of microcephaly
[23, 24].

Table 1. Antibody titres to Zika virus (ZIKV) and Dengue virus (DENV)
serotypes 1 to 4 in patients with severe ocular complications postZIKV infection
Patient

ZIKV
IgG

Case 1

1785

288

Case 2

3320

1084

Case 3

836

1885

3463

4913

Mother of
Case 3

DENV 1
IgG

DENV 2
IgG

DENV 3
IgG

DENV 4
IgG

226

276

312

11521

6706

752

1374

1465

1424

2729

3676

3014
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Fig. 2. Patient described in Case 2. (a) Fundus examination revealed optic disc pallor and an edematous nerve fibre layer. Due to poor
visual acuity, the patient was unable to perform visual field or optical coherence tomography (OCT) scans. (b) Magnetic resonance
imaging (MRI) of the brain showing no abnormalities.

Current knowledge of the natural history of ZIKV is insufficient to identify who is at risk for severe or long-term
adverse outcomes; therefore, it is difficult to determine why
some ZIKV-infected individuals develop serious ocular
complications and others do not. For example, we cannot
explain geographical differences in the proportions and
types of adverse outcomes [8] or variability in the clinical
spectrum and symptomatic rates among infected individuals. The three cases reported herein exhibited IgG antibodies
to all four dengue serotypes; in the case of the newborn,
these are surely of maternal origin. While this demonstrates
that dengue is hyperendemic in Venezuela, it appears to
support the hypothesis that previous immunity to DENV
can play a role in the pathogenesis of severe ZIKV infection
[25]. However, because of the possibilities of (1) severe outcomes being related to previous ZIKV, DENV or both; and
(2) cross-reaction between ZIKV and DENV, it is not possible to rule out prior dengue infection as a reason for the
severe outcomes. A formal case–control study will be
required to clarify whether prior or concurrent DENV infection or vaccination might contribute to severe ocular complications after ZIKV infection, or conversely, if previous
exposure to ZIKV, with or without seropositivity to any of
the DENV serotypes, is a risk factor for severe ocular outcomes. It is interesting to note that individuals who have
been vaccinated against dengue can experience more severe
symptoms and prognosis when exposed to a new strain
[26]. This situation is believed to be mediated by antibodydependent enhancement, in which specific antibodies to the
previously infecting DENV serotype facilitate the entry of a
newly infecting DENV serotype into host cells. The amino
acid sequence of DENV and ZIKV differ by 41–46 %, and
antibodies to these viruses have been shown to be crossreactive [27].

ZIKV infection, as well as newborns whose mothers were
infected during pregnancy, be carefully assessed to determine early signs of vision loss. Patients should be educated
about the potential risk, to raise awareness and increase
early detection, and undergo a complete ophthalmological
examination if necessary. Patients with a history of ZIKV or
DENV infection who present optic neuritis not explained
by any other cause should be tested for antibodies against
ZIKV, DENV 1–4 and possibly other arboviruses. Welldesigned epidemiological studies are urgently needed to
measure the risk of ZIKV ocular complications and to confirm whether they are associated with the presence of antiflaviviral antibodies.
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